• Profile

ATM mutation is associated with shorter overall survival in relapsed/advanced urothelial cancer

Journal of Clinical Oncology Mar 06, 2019

Yin M, et al. - Researchers estimated 88 cases to evaluate the prognostic values of mutations in ATM in tumors of subjects with relapsed/advanced (TxN2-3M0-1) urothelial cancer (UC) via 3 independent datasets. They observed the presence of ATM mutations in 14.8%, 11% and 6.2% of the 3 cohorts. They recorded a constant association of ATM mutations with a significantly shorter overall survival (OS) and with a poorer survival as well. Hence, they suggested ATM mutations, a negative prognostic biomarker in relapsed/advanced UC patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen